BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Cardiac Biomarker Diagnostic Kits Market is Growing at a CAGR of 5.2% from 2022 to 2030

  According to the report, the global cardiac biomarker diagnostic kits market was valued at US$ 2.2 Bn in 2021 and is anticipated to grow at a CAGR of 5.2% from 2022 to 2030

  August 10, 2022

   · 

  6 min read
• 

  Business

  Money on the Move: Versant Launches Vector BioPharma and more Funding News

  Versant Ventures launched Vector BioPharma, a company developing a “precision gene delivery platform that is devoid of viral genes.” Rani, REVA Medical and Summit Therapeutics also scored funds.

  August 10, 2022

   · 

  4 min read

   · 

  Hannah Chudleigh
• Business

  Immunocore Reports Second Quarter 2022 Financial Results and Provides Business Update

  Immunocore Holdings plc today announced its financial results for the second quarter ended June 30, 2022 and provided a business update.

  August 10, 2022

   · 

  26 min read
• Business

  Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights

  Zynerba Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2022, and provided an overview of recent operational highlights and a pipeline update.

  August 10, 2022

   · 

  12 min read
• Business

  Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022

  Helius Medical Technologies, Inc. today announced that the Company will release its second quarter 2022 financial results on Monday, August 15, 2022, after the market closes.

  August 10, 2022

   · 

  2 min read
• Business

  TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

  TScan Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2022 and provided business updates.

  August 10, 2022

   · 

  12 min read
• Business

  Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update

  Evaxion Biotech A/S announced today its second quarter 2022 financial results and provided an operational and business update.

  August 10, 2022

   · 

  9 min read
• Business

  Tango Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

  Tango Therapeutics, Inc. reported its financial results for the second quarter ended June 30, 2022 and provided business highlights.

  August 10, 2022

   · 

  13 min read
• Business

  PolyPid Provides Corporate Update and Reports Second Quarter 2022 Financial Results

  PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today provided a corporate update and reported financial results for the three and six months ended June 30, 2022.

  August 10, 2022

   · 

  10 min read
• BioMidwest

  ELIAS Animal Health Research Demonstrates Cancer-Killing Capabilities of Its Activated T Cell Immunotherapy

  ELIAS Animal Health recently presented new mechanism of action data for the ELIAS Cancer Immunotherapy at the 2022 American College of Veterinary Internal Medicine Forum.

  August 10, 2022

   · 

  2 min read